CA2210318A1 - Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen - Google Patents

Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen

Info

Publication number
CA2210318A1
CA2210318A1 CA002210318A CA2210318A CA2210318A1 CA 2210318 A1 CA2210318 A1 CA 2210318A1 CA 002210318 A CA002210318 A CA 002210318A CA 2210318 A CA2210318 A CA 2210318A CA 2210318 A1 CA2210318 A1 CA 2210318A1
Authority
CA
Canada
Prior art keywords
seq
hla
cells
gage
tumor rejection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002210318A
Other languages
English (en)
French (fr)
Inventor
Pierre Van Der Bruggen
Benoit Van Den Eynde
Olivier Debacker
Thierry Boon-Falleur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Cancer Research
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/370,648 external-priority patent/US5648226A/en
Application filed by Individual filed Critical Individual
Publication of CA2210318A1 publication Critical patent/CA2210318A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002210318A 1995-01-10 1996-01-11 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen Abandoned CA2210318A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/370,648 US5648226A (en) 1993-07-22 1995-01-10 Isolated peptides derived from tumor rejection antigens, and their use
US08/370,648 1995-01-10
US08/531,662 1995-09-21
US08/531,662 US5858689A (en) 1993-07-22 1995-09-21 Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof

Publications (1)

Publication Number Publication Date
CA2210318A1 true CA2210318A1 (en) 1996-07-18

Family

ID=27005030

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002210318A Abandoned CA2210318A1 (en) 1995-01-10 1996-01-11 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen

Country Status (13)

Country Link
US (1) US5858689A (cg-RX-API-DMAC7.html)
EP (1) EP0804467B1 (cg-RX-API-DMAC7.html)
JP (1) JP3180123B2 (cg-RX-API-DMAC7.html)
CN (1) CN1110503C (cg-RX-API-DMAC7.html)
AT (1) ATE234858T1 (cg-RX-API-DMAC7.html)
AU (1) AU708840B2 (cg-RX-API-DMAC7.html)
CA (1) CA2210318A1 (cg-RX-API-DMAC7.html)
DE (1) DE69626789T2 (cg-RX-API-DMAC7.html)
DK (1) DK0804467T3 (cg-RX-API-DMAC7.html)
ES (1) ES2192602T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ302821A (cg-RX-API-DMAC7.html)
PT (1) PT804467E (cg-RX-API-DMAC7.html)
WO (1) WO1996021673A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804381A (en) * 1996-10-03 1998-09-08 Cornell Research Foundation Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof
US6805869B2 (en) * 1996-06-12 2004-10-19 Shanghai Cp Guojian Pharmaceutical Co., Ltd. Cellular vaccines and immunotherapeutics and methods for their preparation
DE19715430A1 (de) * 1997-04-14 1998-11-26 Boehringer Mannheim Gmbh Verfahren zur Typisierung von Allelen
US6680191B1 (en) 1997-04-25 2004-01-20 Ludwig Institute For Cancer Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B FAMILIES and uses thereof
WO1999037665A1 (en) * 1998-01-23 1999-07-29 Ludwig Institute For Cancer Research Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
DE19829580A1 (de) * 1998-07-02 2000-01-05 Bosch Gmbh Robert Vorrichtung zur mechanischen Ausrichtung eines Trägersubstrats für elektronische Schaltungen
US6509172B1 (en) * 1998-09-30 2003-01-21 Ludwig Institute For Cancer Research Isolated, truncated nucleic acid which are members of the gage, and uses thereof
EP1545610A4 (en) * 2002-09-06 2006-11-08 Mannkind Corp EPITOPE SEQUENCES
US7178491B2 (en) * 2003-06-05 2007-02-20 Caterpillar Inc Control system and method for engine valve actuator
US20050118186A1 (en) * 2003-06-17 2005-06-02 Chih-Sheng Chiang Combinations of tumor-associated antigens in compositions for various types of cancers
US20060008468A1 (en) * 2004-06-17 2006-01-12 Chih-Sheng Chiang Combinations of tumor-associated antigens in diagnostics for various types of cancers
US20060159689A1 (en) * 2004-06-17 2006-07-20 Chih-Sheng Chiang Combinations of tumor-associated antigens in diagnostics for various types of cancers
WO2006071989A2 (en) * 2004-12-29 2006-07-06 Mannkind Corporation Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
AU2005321898B2 (en) 2004-12-29 2012-07-19 Mannkind Corporation Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
EP2385059A3 (en) 2005-06-17 2012-02-15 Mannkind Corporation Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1294771A (en) * 1969-01-31 1972-11-01 Sandoz Ltd Thyrocalcitonin derivative
US4105538A (en) * 1977-01-21 1978-08-08 Mattox William J Process for the refining of used motor oils and products thereof
US4101538A (en) * 1977-06-13 1978-07-18 Warner-Lambert Nonapeptides and methods for their production
US4686282A (en) * 1983-08-12 1987-08-11 Immunetech, Inc. Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors
EP0190127A1 (en) * 1984-08-10 1986-08-13 MERCK PATENT GmbH Immunotherapeutic polypeptide agents
OA09696A (en) * 1991-05-02 1993-08-30 Seikagaku Kogyo Co Ltd Novel polypeptides with affinity to lipopolysaccharides and their uses
US6696061B1 (en) * 1992-08-11 2004-02-24 President And Fellows Of Harvard College Immunomodulatory peptides
WO1994005269A1 (en) * 1992-09-08 1994-03-17 Centocor, Inc. Peptide inhibitors of selectin binding
NZ263913A (en) * 1993-03-12 1997-10-24 Immulogic Pharma Corp Lol pi protein allergen from ryegrass and related peptides coding sequences, vectors, protein production and use
US5610013A (en) * 1993-07-22 1997-03-11 Ludwig Institute For Cancer Research Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
US5648226A (en) * 1993-07-22 1997-07-15 Ludwig Institute For Cancer Research Isolated peptides derived from tumor rejection antigens, and their use
ATE251640T1 (de) * 1993-07-23 2003-10-15 Kato Yukio Prof Neues chondrozytprotein
ATE227118T1 (de) * 1993-08-02 2002-11-15 Scripps Research Inst Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
ES2224113T5 (es) * 1994-02-16 2009-05-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Polipeptido antigenico asociado al melanoma, epitopos del mismo y vacunas contra melanoma.

Also Published As

Publication number Publication date
NZ302821A (en) 2000-01-28
ES2192602T3 (es) 2003-10-16
JPH10511401A (ja) 1998-11-04
AU4897096A (en) 1996-07-31
WO1996021673A1 (en) 1996-07-18
AU708840B2 (en) 1999-08-12
PT804467E (pt) 2003-06-30
JP3180123B2 (ja) 2001-06-25
CN1176647A (zh) 1998-03-18
DK0804467T3 (da) 2003-04-22
EP0804467A4 (cg-RX-API-DMAC7.html) 1997-12-03
US5858689A (en) 1999-01-12
HK1008228A1 (en) 1999-05-07
ATE234858T1 (de) 2003-04-15
CN1110503C (zh) 2003-06-04
EP0804467B1 (en) 2003-03-19
DE69626789D1 (de) 2003-04-24
DE69626789T2 (de) 2004-03-04
EP0804467A1 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
US5648226A (en) Isolated peptides derived from tumor rejection antigens, and their use
US6110694A (en) Methods for determining complexes of tumor rejection antigens and HLA-Cw*160/molecules
EP0783511B1 (en) Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
US5858689A (en) Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof
WO1995003422A1 (en) Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
US6013481A (en) Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
WO1996021673A9 (en) Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
CA2317492A1 (en) Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
EP0789591B1 (en) Methods for identifying individuals suffering from a cellular abnormality
US6939707B2 (en) Isolated nucleic acid molecules which encode GAGE genes and uses thereof
AU722111C (en) Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof
AU697527B2 (en) Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw*1601 and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued